Back to top
more

Applied Therapeutics (APLT)

(Delayed Data from NSDQ)

$5.24 USD

5.24
483,565

-0.11 (-2.06%)

Updated Jul 24, 2024 04:00 PM ET

After-Market: $5.24 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Here's Why You Should Retain Universal Health (UHS) Stock Now

Increased admissions at both of its operating segments, constant initiatives to bolster its care network and adequate cash generation abilities are likely to drive Universal Health (UHS).

Encompass Health's (EHC) Nationwide Hospital Count Rises to 147

Encompass Health (EHC) opens a 60-bed inpatient rehabilitation hospital in Illinois, sustaining its aim to offer enhanced rehabilitation services throughout the United States.

Molina Healthcare (MOH) Up 32% in a Year: Is More Upside Left?

Continued revenue growth, well-performing Medicaid and Medicare businesses, expense saving initiatives and solid cash balance continue to drive Molina Healthcare (MOH).

Applied Therapeutics Inc. (APLT) Upgraded to Buy: Here's Why

Applied Therapeutics Inc. (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Applied Therapeutics Inc. (APLT) Stock Sinks As Market Gains: What You Should Know

Applied Therapeutics Inc. (APLT) closed at $22.86 in the latest trading session, marking a -0.95% move from the prior day.

Applied Therapeutics Inc. (APLT) Gains As Market Dips: What You Should Know

Applied Therapeutics Inc. (APLT) closed at $20.02 in the latest trading session, marking a +0.05% move from the prior day.

Applied Therapeutics Inc. (APLT) Gains As Market Dips: What You Should Know

In the latest trading session, Applied Therapeutics Inc. (APLT) closed at $24.36, marking a +1.71% move from the previous day.

New Strong Sell Stocks for August 17th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Applied Therapeutics Inc. (APLT) Gains But Lags Market: What You Should Know

In the latest trading session, Applied Therapeutics Inc. (APLT) closed at $25.93, marking a +0.5% move from the previous day.

Ultragenyx (RARE) Loss Narrows Y/Y & Revenues Beat Estimates

Ultragenyx (RARE) reports a narrower-than-expected loss in the second quarter of 2020 and beats sales estimates.

Alexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 Guidance

Alexion (ALXN) beats on earnings and sales in the second quarter of 2020.

Dr. Reddy's (RDY) Q1 Earnings Decline Y/Y, Sales Increase

Dr. Reddy's (RDY) earnings and revenues decline year over year in first-quarter fiscal 2021.

Alkermes' (ALKS) Q2 Earnings & Revenues Surpass Estimates

Alkermes' (ALKS) earnings decline year over year in the second quarter of 2020.

Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know

Applied Therapeutics Inc. (APLT) closed the most recent trading day at $25.74, moving +1.74% from the previous trading session.

What to Expect for Applied Therapeutics (APLT) Q2 Earnings

During Applied Therapeutics' (APLT) upcoming Q2 earnings call, investor focus will be on the company's progress with its novel pipeline candidates targeting areas of high unmet medical need.

Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services

Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services

LogicBio Therapeutics (LOGC) Catches Eye: Stock Jumps 7.1%

LogicBio Therapeutics (LOGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Shrabana Mukherjee headshot

4 Stocks to Make the Most of New Analyst Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know

Applied Therapeutics Inc. (APLT) closed the most recent trading day at $28.36, moving +0.32% from the previous trading session.

Moderna (MRNA) in Focus: Stock Moves 6.9% Higher

Moderna (MRNA) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Principia Biopharma (PRNB) Jumps: Stock Rises 6.8%

Principia Biopharma (PRNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

BeiGene (BGNE) in Focus: Stock Moves 8.7% Higher

BeiGene (BGNE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

Is (APLT) Outperforming Other Medical Stocks This Year?

Prothena (PRTA) Looks Good: Stock Adds 10.6% in Session

Prothena (PRTA) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

89bio (ETNB) Jumps: Stock Rises 6.9%

89bio (ETNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.